review of isoenzvme characterization of Entamoeba histolytica with particular reference to pathogenic and non-pathogenic stocks isolated in Mexico. Arch Invest Med (Mex) 1982;13(suppl 3):89-94. These findings are consistent with other studies and relevant to the interpretation of minor increases of leukaemia both in population and in individual based studies. If causal they also imply that smoking is responsible for many more deaths from leukaemia in adults than all other known causes combined.
Introduction
The veterans' smoking study, a prospective study of a cohort of United States veterans initiated in 1954, has been an important source of information on the effects of smoking on mortality.` '4 In the latest published analysis (1980) , covering 16 years of observation , a more than 50% increase in mortality from leukaemia was reported among current cigarette smokers as compared with non-smokers. 4 In this study we have investigated the relation between smoking and leukaemia with reference to the amount and type of tobacco smoked and also to certain subtypes of the disease.
Subjects and methods
Deaths from leukaemia in the period 1954-69 were identified among the 248 046 United States veterans holding government life insurance policies who had provided details of their smoking habits in 1954 or 1957. Causes of death had been coded according to the seventh revision of the International Classification of Diseases (ICD). The Leukaemia has in general not been regarded as a malignancy related to smoking, though a higher mortality from leukaemia among smokers has been reported in several studies and to which Austin and Cole have recently drawn attention.6 Thus an excess of similar magnitude was described both in the veterans' study" and in the other large prospective study of smoking in the United States by the American Cancer Society. Other prospective studies that included details of leukaemia found much smaller numbers of deaths from this cause-namely, 30 in a Californian study of men (relative risk 1-3 for cigarette smokers') and 33 in a Japanese study of men (relative risk 0 89). The study of British doctors did not include details of deaths from leukaemia but reported only that among the 152 deaths from marrow and reticuloendothelial malignancies (in which leukaemias are grouped with myeloma and lymphomas) there was a negative relation with cigarette smoking."' More than 70% of these deaths were from lymphomas and myeloma, but analysis of the 43 deaths from leukaemia yielded no sign of an excess among smokers. We note, however, that there were only 11 deaths in the non-smoking reference group (R Peto and R Gray, personal communication). The findings in these smaller prospective studies, though negative, would still be consistent with a moderate increase in mortality due to leukaemia associated with smoking.
A fourth prospective study (though analysed by the case-control approach) of men who had attended universities in the United States found 41 deaths from myeloid leukaemia; a significant excess of these occurred among smokers compared with non-smokers (relative risk 2 4, confidence limits 1 1 and 5 3), but the same was not true for the 27 deaths from lymphatic leukaemia (relative risk 1-3, confidence limits 0 5 and 3-2)."1 Few case-control studies of leukaemia have included data on smoking habits; the main exceptions were those by Williams and Hom'2 and Severson.' In both these studies many of those approached refused to participate, so that the response rates were only 57% and 69% respectively, but in each an excess of myeloid leukaemia among smokers compared with non-smokers was noted.
The excess of leukaemia, and particularly myeloid leukaemia, associated with smoking in this study of 723 deaths seems unlikely to be due to chance, given both its statistical significance and the dose-response relation. Nor can it be easily attributed to underdiagnosis in the reference group (the non-smokers), given that in the United States income and education are inversely related to smoking, so that medical facilities would tend to be more, not less, available in that group. Metastases to the marrow from a bronchial carcinoma may produce a leucoerythroblastic anaemia that might be misdiagnosed as leukaemia, though hardly on the scale necessary to explain the excess found in our study. Nevertheless, and despite the dose-response relation, the magnitude of the excess is small enough for an indirect relation to be possible. We know from many studies that the diet of smokers differs from that of non-smokers in several respects, such as a higher consumption of alcohol and coffee and a lower intake of vegetables. None of these dietary constituents is known to influence the risk of leukaemia, though in one study coffee drinking was found to be associated with a higher mortality from leukaemia. '4 Biologically a relation between smoking and leukaemia is not implausible. Many constituents of tobacco smoke reach the blood, presumably including the carcinogens responsible for the increase in, say, bladder cancer. Moreover, smoking is known to affect the white cells, increasing the numbers ofgranulocytes, monocytes, and lymphocytes.' I6 The explanation for this leucocytosis is unknown, though the fact that there is no appreciable change in the differential white cell count weighs against chronic bronchitis as the sole cause. In this connection the fact that ex-smokers as well as current smokers show a raised white cell count'6 is of interest in view of the increased mortality from leukaemia of both groups in this study.
Two constituents of tobacco smoke that have been linked to leukaemia may be mentioned-namely, radioactive substances and benzene. Radioactive substances can be dismissed as they can hardly be regarded as relevant to the excess of leukaemia among smokers. Radioactive substances are mainly represented by polonium-2 10, but the tiny amounts inhaled by smokers are much smaller than those absorbed from food. 2""Po from such sources makes only a small contribution to the total background irradiation of the marrow.'7 It may be estimated that the 210po inhaled in cigarette smoke will increase marrow irradiation from natural background sources only by one 10th and probably less; such an increase in leukaemia is unlikely to be detectable epidemiologically. With regard to the small amounts of benzene in cigarette smoke (10-100 ,ug per cigarette6) we do not know how the resulting blood concentrations compare with those among the benzene workers who in the past experienced substantial increases in mortality due to leukaemia. These workers were presumably exposed to much higher concentrations than those permitted under the recent United States occupational standard of 32 jig/l ambient air. Even this represents an exposure many times greater than that in the smoke of 20 cigarettes daily. On present evidence it seems unlikely that benzene is the sole cause of the increase of leukaemia among smokers. The question would be helped, however, by more data both on the amounts of benzene absorbed from tobacco smoke compared with the workplace and on the dose-response relation of benzene and leukaemia in occupational studies.
Finding a significant dose-response relation between myeloid leukaemia and the amount of tobacco smoked in this, the largest study of leukaemia and smoking habits to date represents additional evidence that leukaemia is a smoking related disease. In particular, this has relevance in the interpretation of minor increases in the mortality from and incidence of leukaemia in both population based and individual based studies. 
ONE HUNDRED YEARS AGO
The "able editor" is proverbially infallible, and assuredly we should be the last to question his prerogative. If, however, the Achilles of the daily press has a vulnerable heel, it is to be found in the domain of medicine. The comments of the newspapers on medical topics too often tend rather to the amusement than to the edification of the professional mind. Not long ago the wildest havoc was played with the pathology and surgery of the larynx, and the spectacle, dear to the gods, was presented day after day of good men struggling with the adversity of having to "explain" matters which they themselves did not in the least understand. Now, incised wounds of the throat have taken the place of cancer, and the phrenic nerve and carotid artery that of the vocal cords and the epiglottis. An evening paper lately made the startling announcement that General Boulanger was in danger of suffocation "by haematuria in the respiratory channels!" A little time before, the Paris Figaro had thrilled its readers with a sensational account of the agonies which the Emperor Frederick did not suffer, but which the French scribe thought he ought to have suffered. If the public insists on having the sickroom of distinguished patients turned into a clinical theatre for its delectation, it would be well that the demonstrators should be persons having some rudimentary knowledge of their subject. (British Medical Journal 1888;ii:135)
